000 01528 a2200349 4500
005 20250516175022.0
264 0 _c20150223
008 201502s 0 0 eng d
022 _a1875-6638
024 7 _a10.2174/15734064113096660068
_2doi
040 _aNLM
_beng
_cNLM
100 1 _aFeng, Taotao
245 0 0 _aThe discovery of novel histone lysine methyltransferase G9a inhibitors (part 1): molecular design based on a series of substituted 2,4-diamino-7- aminoalkoxyquinazoline by molecular-docking-guided 3D quantitative structure-activity relationship studies.
_h[electronic resource]
260 _bMedicinal chemistry (Shariqah (United Arab Emirates))
_cJun 2014
300 _a426-40 p.
_bdigital
500 _aPublication Type: Journal Article; Research Support, Non-U.S. Gov't
650 0 4 _aDose-Response Relationship, Drug
650 0 4 _aDrug Discovery
650 0 4 _aEnzyme Inhibitors
_xchemical synthesis
650 0 4 _aHistone-Lysine N-Methyltransferase
_xantagonists & inhibitors
650 0 4 _aHumans
650 0 4 _aMolecular Docking Simulation
650 0 4 _aMolecular Structure
650 0 4 _aQuantitative Structure-Activity Relationship
650 0 4 _aQuinazolines
_xchemical synthesis
700 1 _aWang, Hai
700 1 _aZhang, Xiaojin
700 1 _aSun, Haopeng
700 1 _aYou, Qidong
773 0 _tMedicinal chemistry (Shariqah (United Arab Emirates))
_gvol. 10
_gno. 4
_gp. 426-40
856 4 0 _uhttps://doi.org/10.2174/15734064113096660068
_zAvailable from publisher's website
999 _c23195594
_d23195594